Zoe Yu Tung Law

A joint proposition connecting upstream metabolic modelling with downstream process optimisation, TEA, and LCA — so teams can make better decisions from cell to product. New Wave Biotech is pleased to announce a strategic partnership with iMEAN, bringing together two complementary areas of expertise to help biomanufacturers make better process decisions across the full bioprocess. By connecting iMEAN's upstream metabolic modelling and strain design capabilities with New Wave Biotech's...

New Wave Biotech has partnered with Nurasa to accelerate the scale-up of sustainable food and ingredient innovations. By combining New Wave Biotech’s AI-driven bioprocess simulation software with Nurasa’s physical scale-up infrastructure and commercialisation ecosystem, innovators gain early insight into cost, yield and sustainability—reducing risk and speeding the path from R&D to market-ready production across food and biomanufacturing

New Wave Biotech, an innovator in bioprocess optimisation, has launched the industry’s first biotech-specific Life Cycle Assessment (LCA) solution. Fully integrated into its AI-powered process simulation platform, the new capability allows biomanufacturers to quantify and compare the environmental impact of their processes, from climate change and energy output to land and water use, while simultaneously optimising for cost and performance.